McKinsey & Company in partnership with LeanIn.Org recently released its ninth annual Women in the Workplace report. Key takeaways that stood out for me are: (1) The number of women in executive leadership and C-suite positions remains lower than what companies should maintain to gain the benefits of having a diverse leadership team At Johnson & Johnson, I have observed that women are in executive leadership roles, especially in areas where the company is leading – i.e., supply chain and leading therapeutic areas, like oncology. We can always strive to increase this, particularly representation of women of color in executive roles. (2) Women are more ambitious than before the COVID-19 pandemic, and flexibility in the workplace is fueling this I see the benefits of working in a flexible working environment that allows women to balance personal and professional needs. This is particularly important in global positions where one is often working with colleagues across many time zones. J&J has generous policies with regards to family caregiving and other personal needs in recognition of the diverse needs of our people. It’s a more human approach to our work that I appreciate as a woman and mom working in a global environment. I also witness this increase in ambitious women and have the honor of sponsoring several of them at J&J. Read the full report here: https://lnkd.in/eQKj7qq5. What are your thoughts? Image: A picture of me with my colleagues Virginie Lasserre, Tahera Kan and Mohamed-Ramzi TEMANNI, PhD. during a recent European leadership meeting in Paris #womenleadership #womenintheworkplace
Emmanuelle Quiles’ Post
More Relevant Posts
-
Our scientific experts at Johnson & Johnson Innovative Medicine are working to close the gap in unmet needs for cardiovascular patients living with thrombotic conditions like acute coronary syndromes. This #WorldHeartDay, I encourage you to explore how my colleagues are teaming up with Bristol Myers Squibb to help up the ante in thrombotic care. #MyCompany #Heath&Care
Despite advances in antithrombotic treatment, cardiovascular disease and ischemic stroke remain the two leading causes of death worldwide. The potential limitations of available therapies may still carry a risk of bleeding for many people, leaving patients untreated or undertreated. Our Phase 3 Librexia program in collaboration with Bristol Myers Squibb aims to help close those gaps. #WorldHeartDay
-
It’s been a week full of creativity and productivity! Our Basel campus at Johnson & Johnson is thriving with a remarkable level of activity and engagement. I appreciate the vibrancy of our community and the collective efforts that make our campus such a vital place for growth and success. ➡️ The Swiss Technology Community gathered here for the JJT Swiss Credo Event, which is an incredible opportunity for knowledge-sharing and collaboration ➡️ And just this past Monday, we had the pleasure of welcoming John C. Reed, Executive Vice President, Johnson & Johnson Innovative Medicine R&D, as he toured several of the Swiss R&D sites. It was a great opportunity for our colleagues to network, exchange ideas and ask questions ➡️ And to top it off, our Employee Resource Groups on Campus organized a breakfast for everyone to get together. It was a great way to catch up with so many colleagues from across various functions #innovation #MyCompany #Heath&Care #WorkCulture #Collaboration #ExcellenceInAction #JJTSwissCredo #Innovation #Networking #WiSTEM #mycompany #Community Switzerland Innovation Park Basel Area, Basel Area Business & Innovation, Olivier Leconte, Elisabeth Aarefjord, Jane Shaw, Audrey Muller, Chris Easton, Claas S., Cecile Valette, Benjamin Frauchiger Gwen MacDonald Madeux Alessandra Agostini, PhD Aleksandra (Ola) Nowak Dayana Flores Andres Barchilon Marian Sollmann
-
-
With women and people of color historically underrepresented in clinical trials, cardiovascular research for diseases including #AtrialFibrillation (AFib) has gaps in knowledge and disparities in overall health outcomes. That’s why our researchers at Johnson & Johnson Innovative Medicine in collaboration with Bristol Myers Squibb are focusing on inclusive patient enrollment in the Phase 3 Librexia program in pursuit of meaningful improvements for all. #AFibAwarenessMonth #MyCompany
A diverse representation of patients in clinical trials is essential to help advance cardiovascular care and ensure diseases like #AtrialFibrillation (AFib) are more accurately understood and managed. In the Phase 3 Librexia program with Bristol Myers Squibb, our researchers are prioritizing inclusive patient enrollment across three indication-seeking studies in stroke, ACS and AFib to address potential gaps in knowledge and disparities in heart health outcomes. #AFibAwarenessMonth
-
-
As Site Head for Johnson & Johnson's office in Basel, Switzerland, I’m excited to welcome Chantal Dähler, our new Senior Campus Development Specialist, in her new role. Chantal and I work closely together to support the office and celebrate the innovative spirit of this site, which is located in the middle of Switzerland Innovation Park, a community of science-based companies. Chantal’s effort focuses on making the Basel Campus an engaging site for our employees. She is the human touch to the office as she oversees all activities that contribute to the conditions of our success: business-friendly spaces, well-being projects, ERG and community opportunities. Thanks, Chantal, for being that positive person who anticipates our needs and supports us on a daily basis. You help us to be at our best when we’re in the office. What do you like best about the people who support onsite activities for your company? Tag them below. #innovation #MyCompany #Heath&Care Switzerland Innovation Park Basel Area, Basel Area Business & Innovation, Olivier Leconte, Elisabeth Aarefjord, Jane Shaw, Joseph W., Laura de Caso Basalo, Marc Streule, Charlotte Roth, Emanuele Pozzoni, Michael R Huebner, Sylvia Szabo, Chris Brotherton, Natalia Yannoulis, Claas S., Sodexo, ZVF, Handelskammer Beider Basel, Gwen MacDonald Madeux, Alessandra Agostini, PhD, Aleksandra (Ola) Nowak, Rebecca W., Vanessa Dalton, Lory Bonaviva, Swapna Pillai-Amarnath, Dayana Flores, Louise Tong, Sonia Abkorovits, Christoph Mutter, Katharina Pfister, Andres Barchilon
-
-
#AtrialFibrillation (AFib) is a disorder of the heart’s conduction system that causes an abnormal heart rhythm, or rapid and irregular beating. Many patients living with this disease are in need of treatment options that help reduce their risk of heart attack and stroke while taking into account their risk of bleeding. My colleagues at Johnson & Johnson Innovative Medicine, along with researchers from Bristol Myers Squibb, are hard at work to make meaningful improvements for people with AFib. #AFibAwarenessMonth #MyCompany
It is possible to help reduce the risk of cardiovascular events associated with #AtrialFibrillation (AFib), like stroke, but many patients may remain untreated or undertreated due to their risk of bleeding. Our scientists are collaborating with Bristol Myers Squibb to explore the potential of Factor XIa inhibition and help improve outcomes for people living with thrombotic diseases, like AFib. #AFibAwarenessMonth
-
Gifting an experience rather than an object, this is what my children have been doing for years now. This week I enjoyed their incredible birthday present: tickets to attend the horse dressage competition of the #Paralympics #Paris2024 together! 🐴 My two daughters and I have been fond of horse riding forever... But Friday was a different experience and it was so emotional. We watched extraordinary athletes compete, lead their horse in challenging exercises and demonstrate their immense abilities to overcome limitations. Not only do they have extraordinary minds but also powerful bonds with their horses. One of my favorite moments was the hugs they shared at the end of each performance. We discovered a different way to show appreciation for their achievements: 🥇Watching the show in silence 🥈Applauding to support the duos of athletes (rider and horse) by waving our "butterfly wings" (using our arms and hands) 🥉Enjoying the emotional support provided by « friendly horses » to their competing colleagues I have certainly walked away with an improved awareness and appreciation for people with different abilities, that I will continue to carry in my everyday life. Have you watched the Paralympics this year or before? How did it make you feel? What are your learnings for everyday life? Thank you Max Boulanger Marie-Lou Viollet Julie Viollet !
-
-
I am proud to showcase our site in Switzerland and the great work and talents focused on innovation here. It was exciting to have colleagues from all Swiss sites join us for the day. Our annual Swiss-wide Town Hall was a very lively event and great opportunity to reconnect with colleagues from all functions and meet live with some employee resource group members as well.
Yesterday, we hosted our largest event of the year – our annual Swiss-wide Town Hall with insights from our Leadership Team and external guest speakers. Over 200 employees gathered in person at our Basel Campus, while 800 more joined virtually from eight streaming sites across Switzerland. Together, we united under the new Johnson & Johnson brand, showcasing our strong presence in Switzerland and launching the next phase of our journey. Exciting times ahead! Thank you to all the speakers for sharing your insights! Emmanuelle Quiles, Sarah Mueller, Roman Iselin, Max Pahlow, Markus A. Ziegler, Patrick Bonaccio, Damian Müller, Rahul Sahgal #TownHall #Basel #JNJswitzerland
-
This weekend, I’m joined by colleagues from Johnson & Johnson Innovative Medicine and Johnson & Johnson MedTech at the #ESCCongress in London. The congress is hosted by the European Society of Cardiology with the shared goal of advancing cardiovascular medicine worldwide. ESC 2024 is centered around "Personalising Cardiovascular Care,” a topic devoted to empowering patients through tailored treatments to improve outcomes, reduce risk and redefine the standard of care. I’m proud of the efforts of #MyCompany that are specifically centered around this initiative as we’re leading where medicine is going to advance cardiology care. Our Phase 3 Librexia program, in collaboration with our partners at Bristol Myers Squibb, is the most comprehensive FXIa development program to date and aims to close the gap in unmet needs in thrombosis management. At this year’s congress, learn more about our efforts to potentially transform the cardiovascular space. Looking forward to seeing you here! Callie Parker, Dr. Philipp Ruppelt, Trevor Dekker #Heath&Care
-
-
Being in my hometown of Paris, France during the Olympics is a magical experience. Despite having lived here for more than 45 years, I didn’t expect that walking among the millions of enthusiastic tourists would allow me to see the city as if I was experiencing it for the first time. As an engineer, I especially appreciated seeing the technology of the Olympic torch in person. And as a woman, it was exciting to know that the International Olympic Committee – IOC has dubbed the 2024 Paris Games the #GenderEqualOlympics, with an equal number of women and men competing for the first time. What is your favorite sport to watch during the Summer Olympic Games? #Paris2024 #Olympiques2024 #Heath&Care
-
-
My family and I recently visited Québec in Canada. I appreciated the French influence of the city, as a native from France. And although we share the same language, the culture of Quebec is very different from my homeland. I enjoyed speaking to the welcoming locals about the differences. For instance, in Quebec I noticed that • people spoke using traditional French (e.g., saying “souper” instead of “diner” for the evening meal and “bon matin” instead of “bonjour” for good morning). But at the same time, they used the direct “Tu” instead of “Vous” even with me, someone they did not know. This is proof that not all cultures with the same language are exactly alike • people did not cross the street when the streetlight was red. I guess we in France can take a page from that book for safety! • they didn’t greet each other with kisses the way we do in France. I tend to like our greeting better! 😊 Celebrating our shared culture and learning from our differences is both a personal and professional commitment of mine. A way of working that is embraced at Johnson & Johnson Innovative Medicine. Have you visited a new place recently? If so, what was a surprising or unique aspect of the place? #culture #Quebec #Heath&Care
-
